Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Summary

The purpose of this study is to determine the dosing strategy for adolescents aged 2 to 5 years.

Timeline

Start

—

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped: “The company currently does not have plans to conduct this study”

Drugs

Indications